MBNL1 and myotonic dystrophy type 1: It has been previously shown that disaggregating these RNA foci by antisense oligonucleotide (ASO) or morpholino repletes MBNL1 [24,25,26], rescues the DM1 spliceopathy, and alleviates signs and symptoms including myotonia [24,25].